SPRC — Scisparc Share Price
Last trade - 00:00- $3.13m
- $1.58m
- $1.31m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.38 | ||
| Price to Tang. Book | 0.38 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 1.35 | 2.88 | 1.31 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Directors
- Itschak Shrem CHM (74)
- Amitay Weiss CEO (59)
- Oz Adler CFO (34)
- Adi Zuloff-Shani CTO (53)
- Moshe Revach DRC (44)
- Liat Sidi DRC (46)
- Alon Dayan IND (45)
- Ari Shamiss IND (62)
- Amnon Shay IND (58)
- Lior Vider IND (44)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2018
- Incorporated
- August 23rd, 2004
- Public Since
- December 22nd, 2021
- No. of Employees
- 2
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 10,828,251
- Address
- 20 Raul Wallenberg Street, Tower A, TEL AVIV-YAFO, 6971916
- Web
- https://scisparc.com/
- Phone
- +972 36103100
- Auditors
- Kost, Forer, Gabbay & Kasierer
Upcoming Events for SPRC
Similar to SPRC
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Akari Therapeutics
NASDAQ Capital Market
Akebia Therapeutics
NASDAQ Capital Market
Alpha Cognition
NASDAQ Capital Market
FAQ
As of Today at 23:07 UTC, shares in Scisparc are trading at $0.29. This share price information is delayed by 15 minutes.
Shares in Scisparc last closed at $0.29 and the price had moved by -77.06% over the past 365 days. In terms of relative price strength the Scisparc share price has underperformed the S&P500 Index by -79.32% over the past year.
There is no consensus recommendation for this security.
Find out moreScisparc does not currently pay a dividend.
Scisparc does not currently pay a dividend.
Scisparc does not currently pay a dividend.
To buy shares in Scisparc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.29, shares in Scisparc had a market capitalisation of $3.13m.
Here are the trading details for Scisparc:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SPRC
Based on an overall assessment of its quality, value and momentum Scisparc is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Scisparc. Over the past six months, its share price has outperformed the S&P500 Index by +24.55%.
As of the last closing price of $0.29, shares in Scisparc were trading -18.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Scisparc PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Scisparc's management team is headed by:
- Itschak Shrem - CHM
- Amitay Weiss - CEO
- Oz Adler - CFO
- Adi Zuloff-Shani - CTO
- Moshe Revach - DRC
- Liat Sidi - DRC
- Alon Dayan - IND
- Ari Shamiss - IND
- Amnon Shay - IND
- Lior Vider - IND